Each tablet of Phenergan contains 12.5 mg, 25 mg, or 50 mg promethazine HCl.The inactive ingredients present are lactose, magnesium stearate, and methylcellulose.Use of Phenergan Tablets and Suppositories in patients with compromised respiratory function (e.g., COPD, sleep apnea) should be avoided.
The diagnostic evaluation of patients with this syndrome is complicated.
Therapy adjunctive to meperidine or other analgesics for control of post-operative pain.
Sedation in both children and adults, as well as relief of apprehension and production of light sleep from which the patient can be easily aroused.
Amelioration of allergic reactions to blood or plasma. Anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled.
Preoperative, postoperative, or obstetric sedation. Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery.